Patrick Vanderdonckt

Author

Also Known As

P. VANDERDONCKT, P. Vanderdonckt, Patrick Vanderdonckt, Paul Bourgeois, Vanderdonckt, P.

Publications

332

Citations

H-Index

Concepts

All Affiliations

Patrick Vanderdonckt is an author at Ghent University Hospital specializing in medicine, histopathology, and clinical trials.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	38
2	Public Health	1	1	23
3	Epidemiology	1	1	23
4	Neurology	1	1	23
5	Pathology	1	1	15

Patrick Vanderdonckt

Publications

110

Citations

H-Index

Page 1

	Year	Citations
Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience Marie D’hooghe, Barbara Willekens, Valérie Delvaux, BMC Neurology	2021	35
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program Vincent Van Pesch, E Bartholomé, Véronique Bissay, Acta Neurologica Belgica Disease ProgressionSystemic SclerodermaMedicineClinical EpidemiologyClinical Trials	2014	23
A double-blind study of neurotropin in patients with acute ischemic stroke Jacques De Reuck, D. Decoo, Patrick Vanderdonckt, Acta Neurologica Scandinavica	2009	19
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting María Trojano, Helmut Butzkueven, Ludwig Kappos, Multiple Sclerosis and Related Disorders	2018	18
Choroid plexus and ependymal cells in CSF cytology Jacques De Reuck, Patrick Vanderdonckt Clinical Neurology and Neurosurgery HistopathologyPathologyCsf CytologyChoroid PlexusMedicine	1986	15

Page 1